NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-036-2018-0-US-03 HEPTAMETHINE CYANINES FOR USE AS FLUORESCENT MARKERS OF THE BILIARY AND RENAL SYSTEMS US CON 18/358,068 Pending
NCI E-256-2020-0-US-04 IMIDAZO[1,2-A]PYRAZINE AND IMIDAZO[1,2-A]PYRIDINE BASED TYROSYL-DNA
PHOSPHODIESTERASE I (TDP1) INHIBITORS 		US National Stage 18/262,779 Pending
NEI E-293-2016-0-US-02 TISSUE CLAMP AND IMPLANTATION METHOD US DIV 18/226,043 Pending
NHLBI E-056-2021-0-IL-01 A New Molecular Scaffold For Targeting HRpn13 IL National Stage 304725 Pending
NIAID E-037-2021-1-CA-04 Antibodies Targeting The Spike Protein Of Coronaviruses CA National Stage 3209136 Pending
NIDDK E-051-2021-0-AU-01 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS AU National Stage 2022207045 Pending
NEI E-033-2021-0-AU-01 EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF AU National Stage 2021417166 Pending
NIAID E-055-2021-0-IN-01 Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use IN National Stage 202317048886 Pending
NIAID E-037-2021-1-IN-09 Antibodies Targeting The Spike Protein Of Coronaviruses IN National Stage 202317048889 Pending
NIAID E-139-2006-0-US-02 Development Of Dengue Virus Vaccine Components US CON 18/355,265 Pending
NCI E-067-2017-0-JP-01 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES JP DIV 2023-117842 Pending
NIAID E-297-2016-2-IN-01 VACCINE CANDIDATES FOR HUMAN RESPIRATORY SYNCYTIAL VIRUS (RSV) HAVING ATTENUATED PHENOTYPES IN DIV 202318048655 Pending
NIAID E-055-2021-0-EP-01 Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use EP National Stage 22703165.5 Pending
NIDDK E-051-2021-0-CA-01 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS CA National Stage 3208662 Pending
NIAID E-055-2021-0-CN-01 Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use CN National Stage 202280010458.8 Pending
NCI E-087-2015-1-EP-05 Methods and Compositions for Inducing an Immune Response Using Conserved Element Constructs EP DIV 23185862.2 Pending
NCI E-182-2017-0-EP-01 METHODS FOR SELECTIVELY EXPANDING CELLS EXPRESSING A TCR WITH A MURINE CONSTANT REGION EP DIV 23185846.5 Pending
NEI E-013-2021-0-EP-01 COMPOSITION AND METHOD OF PRESERVING VIABILITY OF CELL IN A LOW TEMPERATURE EP National Stage 21844141.8 Pending
NCI E-243-2020-0-AU-01 NEAR INFRARED PHOTOIMMUNOTHERAPY (NIR-PIT) COMBINATION THERAPY TO TREAT CANCER AU National Stage 2022213415 Pending
NIAID E-037-2021-1-AU-02 Antibodies Targeting The Spike Protein Of Coronaviruses AU National Stage 2022221297 Pending
NCI E-044-2022-0-PCT-01 KINASE INHIBITORS PCT PCT PCT/US2023/070304 Pending
NCATS E-035-2020-1-US-03 TREATING PRIMARY OR IDIOPATHIC HYPEROXALURIA WITH SMALL MOLECULE INHIBITORS OF LACTATE DEHYDROGENASE US CON 18/352,721 Pending
NIAID E-055-2021-0-JP-01 Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use JP National Stage 2023-543164 Pending
NIDDK E-051-2021-0-US-02 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS US National Stage 18/272,435 Pending
NIDA E-023-2018-0-US-05 DREADD ACTUATORS US DIV 18/221,475 Pending
NIAID E-055-2021-0-US-02 Replication-Competent Adenovirus Type 4-SARS-CoV-2 Vaccines And Their Use US National Stage 18/271,901 Pending
NIAID E-157-2022-0-PC-01 SARS-CoV-2 COMPOSITIONS AND METHODS FOR TREATMENT OF VIRUS-INDUCED AIRWAY FIBROSIS PCT PCT PCT/US2023/069899 Pending
NHLBI E-197-2020-0-CN-01 SINGLE-CELL PROFILING OF CHROMATIN OCCUPANCY AND RNA SEQUENCING CN National Stage 202180089986.2 Abandoned
NEI E-033-2021-0-US-02 EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF US National Stage 18/271,583 Pending
NIAID E-202-2008-0-US-20 INHIBITORS OF THE PLASMODIAL SURFACE ANION CHANNEL AS ANTIMALARIALS US DIV 18/220,090 Pending
NEI E-033-2021-0-JP-01 EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF JP National Stage 2023-541862 Pending
NIDCD E-173-2022-0-PC-01 IMPEDING PLATINUM-BASED CHEMOTHERAPEUTIC INDUCED OTOTOXICITY USING
A COLONY STIMULATING FACTOR 1 RECEPTOR INHIBITOR 		PCT PCT PCT/US2023/069841 Pending
NHLBI E-100-2022-0-PCT-02 VERY-LONG-CHAIN POLYUNSATURATED FATTY ACIDS (VLCPUFA) FOR IMPROVING RETINA/COGNITIVE FUNCTIONS AND ATHEROSCLEROSIS PCT PCT PCT/US2023/027076 Pending
NIBIB E-139-2022-2-PC-01 METHODS AND COMPOSITIONS FOR IMPROVING WOUND HEALING PCT PCT COMB PCT/US2023/069798 Pending
NCI E-076-2022-0-PC-01 CELL-BARCODE RECORDER DEVICES AND METHODS PCT PCT PCT/US2023/069782 Pending
NEI E-033-2021-0-CA-01 EXOSOMES COMPRISING IL-35 OR IL-27 AND USES THEREOF CA National Stage 3204551 Pending
NIBIB E-237-2020-0-JP-01 Systems and Methods for Producing Isotropic In-Plane Super-Resolution Images from Line-Scanning Confocal Microscopy JP National Stage 2023-541648 Pending
NIBIB E-237-2020-0-US-02 Systems and Methods for Producing Isotropic In-Plane Super-Resolution Images from Line-Scanning Confocal Microscopy US National Stage 18/271,202 Pending
NLM E-107-2010-2-US-01 METHODS OF EPIGENETIC ANALYSIS US CON 18/348,096 Pending
NIBIB E-237-2020-0-CN-01 Producing Isotropic Super-Resolution Images From Line Scanning Confocal Microscopy CN National Stage 202280009117.9 Pending
NHLBI E-005-2021-0-CN-01 MODIFIED NK CELLS WITH REDUCED CCR5 EXPRESSION AND METHODS OF THEIR USE CN National Stage 202180089290.X Pending
NCI E-167-2017-0-US-02 CANCER TREATMENT UTILIZING PRE-EXISTING MICROBIAL IMMUNITY US DIV 18/346,680 Pending
NIA E-135-2022-1-PC-01 MONOCLONAL ANTIBODIES DIRECTED TO PHOSPHORYLATED PSD95 AND USES THEREOF PCT PCT PCT/US2023/069503 Pending
NCI E-129-2022-0-PC-01 CD25-SPECIFIC ANTIBODIES AND USES THEREOF PCT PCT PCT/US2023/069461 Pending
NIAID E-197-2023-0-PC-01 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM4] PCT PCT PCT/US2023/069541 Pending
NIAID E-197-2023-1-PC-01 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] PCT PCT PCT/US2023/069538 Pending
NIAID E-197-2023-1-US-04 ANTI-SARS-CoV-2 ANTIGEN BINDING POLYPEPTIDES, POLYPEPTIDE COMPLEXES AND METHODS OF USE THEREOF [COM5] US ORD 18/345,478 Pending
NIAID E-134-2020-1-US-01 ANTIBODY-GUIDED PCSK9-MIMICKING IMMUNOGENS LACKING 9-RESIDUE SEQUENCE OVERLAP WITH HUMAN PROTEINS US National Stage 18/270,436 Pending
NCI E-520-2013-0-US-03 Identification And Characterization Of HLA-A24 Agonist Epitopes Of MUC1-Oncoprotein US CON 18/344,242 Pending
NCI E-158-2022-0-PC-01 IMMUNOGENS AND METHODS FOR INDUCING AN IMMUNE RESPONSE PCT PCT PCT/US2023/069057 Pending